PharmaCorp Rx (TSXV:PCRX) Total Liabilities: C$10.31 Mil (As of Mar. 2026)


TSXV:PCRX PharmaCorp Rx Inc TSXV:PCRX
35 GF Score
Price C$0.58
! 2 Warning Signs
View Full Analysis

What is PharmaCorp Rx Total Liabilities?

PharmaCorp Rx TSXV:PCRX +16.00% 35 Total Liabilities is C$10.31 Mil as of Mar. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

PharmaCorp Rx's Total Liabilities for the quarter that ended in Mar. 2026 was C$10.31 Mil.

PharmaCorp Rx's quarterly Total Liabilities increased from Sep. 2025 (C$9.50 Mil) to Dec. 2025 (C$13.30 Mil) but then declined from Dec. 2025 (C$13.30 Mil) to Mar. 2026 (C$10.31 Mil).

PharmaCorp Rx's annual Total Liabilities increased from Dec. 2023 (C$0.05 Mil) to Dec. 2024 (C$4.64 Mil) and increased from Dec. 2024 (C$4.64 Mil) to Dec. 2025 (C$13.30 Mil).

PharmaCorp Rx Total Liabilities Historical Data

* Premium members only.

The historical data trend for PharmaCorp Rx's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Total Liabilities Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
0.03 0.02 0.05 4.64 13.30

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.62 4.94 9.50 13.30 10.31
TSXV:PCRX
35GF Score
PharmaCorp Rx Inc TSXV:PCRX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCorp Rx Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PharmaCorp Rx's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.81+(4.001+-0.00099999999999945
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+3.49+0+0)
=13.30

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=65.57-52.27
=13.30

PharmaCorp Rx's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.942+(3.936+-8.8817841970013E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+3.428+0+0)
=10.31

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=63.132-52.827
=10.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of C$10.31 Mil mean?
PharmaCorp Rx (TSXV:PCRX) has a Total Liabilities of C$10.31 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Total Liabilities too high?
PharmaCorp Rx's current Total Liabilities is C$10.31 Mil. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Total Liabilities compare to competitors?
PharmaCorp Rx's Total Liabilities of C$10.31 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PharmaCorp Rx and its competitors. PharmaCorp Rx's current Total Liabilities is C$10.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Total Liabilities of C$10.31 Mil. The current Total Liabilities is C$10.31 Mil. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Total Liabilities is C$10.31 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCorp Rx Business Description

Address 303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score

Get the complete analysis for TSXV:PCRX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.58
Price